Clinical Trial Update: Tilrdakizumab Almirall

View source ↗

Summary

A clinical trial evaluating tilrdakizumab for psoriasis is currently active but not recruiting at University Hospital Schleswig-Holstein.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Tilrdakizumab

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Psoriasis | Status: ACTIVE_NOT_RECRUITING